0

CAMPATH از شرکت GENZYME

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CAMPATH از شرکت GENZYME

Biologic License Application (BLA): 103948

Company: GENZYME

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CAMPATH ALEMTUZUMAB 10MG/ML VIAL; INTRAVENOUS Prescription

None

No No
CAMPATH ALEMTUZUMAB 30MG/ML VIAL; INTRAVENOUS Prescription

None

No No
LEMTRADA ALEMTUZUMAB 12MG/1.2ML (10MG/ML) INJECTABLE;INJECTION Prescription

None

No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/07/2001 ORIG-1 Approval

N/A; Orphan

Label

Letter

Review

https://web.archive.org/web/20170222172020/https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm088606.
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/alemmil050701L.htm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/103948s000_CampathTOC.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
08/18/2021 SUPPL-5183 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103948s5183lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/103948Orig1s5183ltr.pdf

04/28/2021 SUPPL-5182 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103948s5182lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/103948Orig1s5182ltr.pdf

10/22/2020 SUPPL-5181 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5181lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/103948Orig1s5181ltr.pdf

03/12/2021 SUPPL-5180 Supplement

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/103948Orig1s5180ltr.pdf

09/25/2020 SUPPL-5179 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5177s5179lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/103948Orig1s5177, s5179ltr.pdf

09/25/2020 SUPPL-5177 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5177s5179lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/103948Orig1s5177, s5179ltr.pdf

06/29/2020 SUPPL-5176 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5176lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/103948Orig1s5176ltr.pdf

05/27/2020 SUPPL-5173 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5173lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/103948Orig1s5173ltr.pdf

07/31/2019 SUPPL-5172 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5172lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/103948Orig1s5172ltr.pdf

11/26/2019 SUPPL-5171 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5171lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/103948Orig1s5171ltr.pdf

10/29/2019 SUPPL-5170 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5169s5170lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/103948Orig1s5169,s5170ltr.pdf

10/29/2019 SUPPL-5169 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5169s5170lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/103948Orig1s5169,s5170ltr.pdf

04/23/2019 SUPPL-5168 Supplement

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/103948Orig1s5168ltr.pdf

11/29/2018 SUPPL-5167 Supplement

Label (PDF)

Letter (PDF)

Label for CAMPATH

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103948s5167lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/103948Orig1s5167ltr.pdf

11/28/2018 SUPPL-5165 Supplement

Label (PDF)

Letter (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103948s5160_5165lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/103948Orig1s5160, s5165ltr.pdf

01/16/2019 SUPPL-5164 Supplement

Label (PDF)

Letter (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5163s5164slbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/103948s5163s5164ltr.pdf

01/16/2019 SUPPL-5163 Supplement

Label (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5163s5164slbl.pdf

11/28/2018 SUPPL-5160 Supplement

Label (PDF)

Letter (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103948s5160_5165lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/103948Orig1s5160, s5165ltr.pdf

12/13/2017 SUPPL-5159 Supplement

Label (PDF)

Letter (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103948s5159lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/103948Orig1s5159ltr.pdf

10/05/2017 SUPPL-5158 Supplement

Label is not available on this site.

10/05/2017 SUPPL-5157 Supplement

Label (PDF)

Label for CAMPATH

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103948s5157lbl.pdf

04/05/2016 SUPPL-5153 Supplement

Label is not available on this site.

09/18/2015 SUPPL-5151 Supplement

Letter (PDF)

Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/103948Orig1s5151ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/103948Orig1s5151.pdf

09/05/2014 SUPPL-5150 Supplement

Label is not available on this site.

11/14/2014 SUPPL-5139 Supplement

Label is not available on this site.

03/30/2009 SUPPL-5092 Supplement

Label is not available on this site.

09/19/2007 SUPPL-5070 Supplement

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/103948s5070lt.pdf

05/19/2004 SUPPL-5035 Supplement

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
08/18/2021 SUPPL-5183

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103948s5183lbl.pdf
04/28/2021 SUPPL-5182

Labeling-Medication Guide

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103948s5182lbl.pdf
04/28/2021 SUPPL-5182

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103948s5182lbl.pdf
10/22/2020 SUPPL-5181

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5181lbl.pdf
09/25/2020 SUPPL-5179

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5177s5179lbl.pdf
09/25/2020 SUPPL-5177

Labeling-Medication Guide

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5177s5179lbl.pdf
09/25/2020 SUPPL-5177

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5177s5179lbl.pdf
06/29/2020 SUPPL-5176

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5176lbl.pdf
05/27/2020 SUPPL-5173

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5173lbl.pdf
11/26/2019 SUPPL-5171

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5171lbl.pdf
10/29/2019 SUPPL-5170

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5169s5170lbl.pdf
10/29/2019 SUPPL-5170

Labeling-Medication Guide

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5169s5170lbl.pdf
10/29/2019 SUPPL-5169

Labeling-Medication Guide

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5169s5170lbl.pdf
10/29/2019 SUPPL-5169

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5169s5170lbl.pdf
07/31/2019 SUPPL-5172

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5172lbl.pdf
01/16/2019 SUPPL-5164

Labeling-Package Insert

Label (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5163s5164slbl.pdf
01/16/2019 SUPPL-5164

Labeling-Medication Guide

Label (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5163s5164slbl.pdf
01/16/2019 SUPPL-5163

Labeling-Package Insert

Label (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5163s5164slbl.pdf
01/16/2019 SUPPL-5163

Labeling-Medication Guide

Label (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5163s5164slbl.pdf
11/29/2018 SUPPL-5167

Labeling-Package Insert

Label (PDF)

Label for CAMPATH

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103948s5167lbl.pdf
11/29/2018 SUPPL-5167

Labeling-Medication Guide

Label (PDF)

Label for CAMPATH

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103948s5167lbl.pdf
11/28/2018 SUPPL-5165

Labeling-Package Insert

Label (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103948s5160_5165lbl.pdf
11/28/2018 SUPPL-5165

Labeling-Medication Guide

Label (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103948s5160_5165lbl.pdf
11/28/2018 SUPPL-5160

Efficacy-Labeling Change With Clinical Data

Label (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103948s5160_5165lbl.pdf
12/13/2017 SUPPL-5159

Labeling-Package Insert

Label (PDF)

Label for LEMTRADA

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103948s5159lbl.pdf
10/05/2017 SUPPL-5157

Labeling-Package Insert

Label (PDF)

Label for CAMPATH

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103948s5157lbl.pdf
05/07/2001 ORIG-1 Approval

https://web.archive.org/web/20170222172020/https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm088606.
حتما بخوانید : CAMBIA از شرکت ASSERTIO
بخوانید  CHLORDIAZEPOXIDE HYDROCHLORIDE از شرکت PARKE DAVIS
برچسب‌ها:,

نظرات کاربران